48% women now prioritizing their own health reveals Redcliffe Labs study

New Delhi: A recent study conducted by Redcliffe Labs under the ‘Let Her Decide’ campaign with a sample size of 1 million revealed a significant increase in women proactively undergoing preventive health checkups and diagnostic tests.

Over the past three years, Redcliffe Labs has witnessed a transformative shift in women's health-seeking behavior. In 2021, women accounted for only 40% of health checkups conducted by the company. However, this percentage has steadily increased, with women comprising 45% in 2022 and an impressive 48% in 2023.

Women across Delhi-NCR, Bangalore, Pune, Mumbai, and Hyderabad exhibit heightened health awareness and actively seek preventive care through timely health checkups. They spend an average of Rs. 999 on healthcare packages from Redcliffe’s affordable and accessible preventive health checkup packages. Also, the HbA1C test for diabetes monitoring, hemogram tests, Rheumatoid Factor (RA) Quantitative Test, and Thyroid Profile Tests emerged as popular choices, highlighting women's proactive approach to managing prevalent health concerns..

Dr. Sohini Sengupta, Medical Laboratory Director, Redcliffe Labs, said, "We aim to support women throughout their health journey. Our ‘Let Her Decide’ campaign is a step towards encouraging women to trust themselves, empowering them to make informed decisions about their well-being. We are thrilled to see women taking charge of their well-being through early detection and prevention.”

Notably, thyroid disorders affect over 11.2% of women in India, making early screening crucial. During Thyroid Awareness Month, Redcliffe Labs conducted a nationwide initiative, offering free Thyroid Tests to empower women with knowledge and resources.